Evidence map›Paper›PMID 35811929›Full record

ArticleACS omega2022

Screening of

Fazli Khuda, Nida Alam, Atif Ali Khan Khalil, Asif Jan, Faiza Naureen, Zaki Ullah, Amal Alotaibi, Riaz Ullah, Sami Ullah, Yasar Shah and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 9 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 3 countries.

Fazli KhudaDepartment of Pharmacy, University of Peshawar, Peshawar 25120, Pakistan.ORCID https://orcid.org/0000-0002-6847-1744
Nida AlamDepartment of Pharmacy, University of Peshawar, Peshawar 25120, Pakistan.
Atif Ali Khan KhalilDepartment of Biological Sciences, National University of Medical Sciences, Rawalpindi 46000, Pakistan.
Asif JanDepartment of Pharmacy, University of Peshawar, Peshawar 25120, Pakistan.
Faiza NaureenDepartment of Pharmacy, Abdul Wali Khan University, Mardan 23200, Pakistan.
Zaki UllahDepartment of Pharmacy, University of Peshawar, Peshawar 25120, Pakistan.
Amal AlotaibiDepartment of Basic Science, College of Medicine, Princess Nourah Bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia.
Riaz UllahDepartment of Pharmacognosy (Medicinal Aromatic and Poisonous Plants Research Center) College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.ORCID https://orcid.org/0000-0002-2860-467X
Sami UllahDepartment of Pharmacy, University of Peshawar, Peshawar 25120, Pakistan.
Yasar ShahDepartment of Pharmacy, Abdul Wali Khan University, Mardan 23200, Pakistan.
Sayyed Ibrahim ShahDepartment of Pharmacy, Abdul Wali Khan University, Mardan 23200, Pakistan.
Sultan Mehtap BüyükerDepartment of Pharmacy Services, Üsküdar University, İstanbul 34664, Turkey.
University of Peshawar · PKAbdul Wali Khan University Mardan · PKKing Saud University · SANational University of Medical Sciences · PKPrincess Nourah bint Abdulrahman University · SAÜsküdar University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Exploring new antimicrobial and cytotoxic drugs has been one of the most active areas of research.

Identifiers

PMID35811929
PMCPMC9260770
OpenAlexW4283024823

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.